Associated Papers
Multiple Immune Defects in Two Patients with Novel DOCK2 Mutations Result in Recurrent Multiple Infection Including Live Attenuated Virus Vaccine.
Li W et al.
Journal of Clinical Immunology, 2023
A novel DOCK2 variant in siblings with severe combined immunodeficiency.
Bruusgaard-Mouritsen MA et al.
Scandinavian Journal of Immunology, 2023
First patient in the Iranian Registry with novel DOCK2 gene mutation, presenting with skeletal tuberculosis, and review of literature.
Sharifinejad N et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology, 2021
Select a paper to view details